During the past decade, Kanizsai Dorottya Hospital conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 12 clinical trials were completed, i.e. on average, 41.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 9 clinical trials were completed. i.e. 69.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kanizsai Dorottya Hospital" #1 sponsor was "Eli Lilly and Company" with 7 trials, followed by "Bayer" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Celgene" with 3 trials sponsored and "Gilead Sciences" with 3 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kanizsai Dorottya Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Allergan" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Kanizsai Dorottya Hospital" are "Type 2 Diabetes Mellitus" (5 trials), "Crohn Disease" (4 trials), "Heart Failure" (4 trials), "Atrial Fibrillation" (2 trials) and "Diabetes Mellitus, Type 2" (2 trials). Many other conditions were trialed in "Kanizsai Dorottya Hospital" in a lesser frequency.

Most popular intervention types in "Kanizsai Dorottya Hospital" are "Drug" (30 trials), "Other" (7 trials), "Behavioral" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Diet" (3 trials), "Dulaglutide" (3 trials), "Exercise" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Kanizsai Dorottya Hospital" are 34 trials for "All" genders.

Currently, there are NaN active trials in "Kanizsai Dorottya Hospital". undefined are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Kanizsai Dorottya Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Kanizsai Dorottya Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 22 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".